Related Experiment Video
Updated: Oct 6, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure
Shahryar M Chowdhury1, Eric M Graham1, Carolyn L Taylor1
1Division of Cardiology Department of Pediatrics Medical University of South Carolina Charleston SC.
Insights
Fontan patients with normal ejection fraction but abnormal diastolic function show reduced exercise capacity and poorer health status. Identifying diastolic dysfunction is key for managing heart failure with preserved ejection fraction (HFpEF) risk.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Physiology
- Congenital Heart Disease
Background:
- Heart failure phenotyping in single-ventricle Fontan patients, especially those with normal ejection fraction (EF), is complex.
- Identifying patients at risk for heart failure with preserved ejection fraction (HFpEF) is crucial for timely intervention.
Purpose of the Study:
- To identify Fontan patients with abnormal diastolic function and normal EF, who are at high risk for HFpEF.
- To characterize the cardiac mechanics, exercise function, and functional health status of these patients.
Main Methods:
- Utilized data from the Pediatric Heart Network Fontan Cross-sectional Study.
- Defined abnormal diastolic function using the diastolic pressure:volume quotient (>90th percentile).
- Categorized patients into control, systolic dysfunction (SD), and diastolic dysfunction (DD) groups.
Main Results:
- Diastolic dysfunction (DD) patients exhibited higher arterial elastance (arterial stiffness) compared to controls.
- DD patients demonstrated lower percent predicted peak VO2, indicating reduced exercise tolerance.
- Both DD and SD groups reported lower Physical Functioning Summary Scores (FSS) than controls.
Conclusions:
- Fontan patients with diastolic dysfunction and normal EF experience decreased exercise tolerance and functional health.
- These patients also present with elevated arterial stiffness, highlighting a significant risk factor.
- Early identification of diastolic dysfunction is feasible and essential for managing HFpEF risk in Fontan survivors.
Abstract:
Background Heart failure phenotyping in single-ventricle Fontan patients is challenging, particularly in patients with normal ejection fraction (EF). The objective of this study was to identify Fontan patients with abnormal diastolic function, who are high risk for heart failure with preserved ejection fraction (HFpEF), and characterize their cardiac mechanics, exercise function, and functional health status. Methods and Results Data were obtained from the Pediatric Heart Network Fontan Cross-sectional Study database. EF was considered abnormal if <50%. Diastolic function was defined as abnormal if the diastolic pressure:volume quotient (lateral E:e'/end-diastolic volume) was >90th percentile (≥0.26 mL-1). Patients were divided into: controls=normal EF and diastolic function; systolic dysfunction (SD) = abnormal EF with normal diastolic function; diastolic dysfunction (DD) = normal EF with abnormal diastolic pressure:volume quotient. Exercise function was quantified as percent predicted peak VO2. Physical Functioning Summary Score (FSS) was reported from the Child Health Questionnaire. A total of 239 patients were included, 177 (74%) control, 36 (15%) SD, and 26 (11%) DD. Median age was 12.2 (5.4) years. Arterial elastance, a measure of arterial stiffness, was higher in DD (3.6±1.1 mm Hg/mL) compared with controls (2.5±0.8 mm Hg/mL), P<0.01. DD patients had lower predicted peak VO2 compared with controls (52% [20] versus 67% [23], P<0.01). Physical FSS was lower in DD (45±13) and SD (44±13) compared with controls (50±7), P<0.01. Conclusions Fontan patients with abnormal diastolic function and normal EF have decreased exercise tolerance, decreased functional health status, and elevated arterial stiffness. Identification of patients at high risk for HFpEF is feasible and should be considered when evaluating Fontan patients.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Mitral Stenosis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Pathophysiology of Heart Failure

